MCRO logo

Macro Group Pharmaceuticals (Macro Capital)ECASE:MCRO Stock Report

Market Cap ج.م1.2b
Share Price
ج.م2.25
My Fair Value
1Y23.7%
7D-1.7%
Portfolio Value
View

Macro Group Pharmaceuticals (Macro Capital) S.A.E

CASE:MCRO Stock Report

Market Cap: ج.م1.2b

MCRO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Macro Group Pharmaceuticals (Macro Capital) S.A.E Competitors

Price History & Performance

Summary of share price highs, lows and changes for Macro Group Pharmaceuticals (Macro Capital)E
Historical stock prices
Current Share Priceج.م2.25
52 Week Highج.م2.70
52 Week Lowج.م1.58
Beta0.015
1 Month Change14.80%
3 Month Change5.63%
1 Year Change23.69%
3 Year Change-28.80%
5 Year Changen/a
Change since IPO-50.11%

Recent News & Updates

Recent updates

Shareholder Returns

MCROEG Personal ProductsEG Market
7D-1.7%-1.7%0.3%
1Y23.7%-9.0%22.3%

Return vs Industry: MCRO exceeded the EG Personal Products industry which returned -8.1% over the past year.

Return vs Market: MCRO exceeded the EG Market which returned 19.8% over the past year.

Price Volatility

Is MCRO's price volatile compared to industry and market?
MCRO volatility
MCRO Average Weekly Movement4.2%
Personal Products Industry Average Movement5.9%
Market Average Movement5.3%
10% most volatile stocks in EG Market9.1%
10% least volatile stocks in EG Market3.3%

Stable Share Price: MCRO has not had significant price volatility in the past 3 months compared to the EG market.

Volatility Over Time: MCRO's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002n/aHisham Wasfywww.macro-egy.com

Macro Group Pharmaceuticals (Macro Capital) S.A.E operates as a cosmeceuticals manufacturing company in Egypt and internationally. It engages in the production of pharmaceutical and cosmetic products, such as skin care, hair care, oral care, female intimate care, anti-scar, antiseptics, and topical muscle relaxants, as well as flavors, colors, and scents. The company also manufactures solid and liquid soap, herbal medicines, products and extracts, nutritional supplements, baby food, and special food products.

Macro Group Pharmaceuticals (Macro Capital) S.A.E Fundamentals Summary

How do Macro Group Pharmaceuticals (Macro Capital)E's earnings and revenue compare to its market cap?
MCRO fundamental statistics
Market capج.م1.25b
Earnings (TTM)ج.م62.40m
Revenue (TTM)ج.م644.82m
20.3x
P/E Ratio
2.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCRO income statement (TTM)
Revenueج.م644.82m
Cost of Revenueج.م237.07m
Gross Profitج.م407.75m
Other Expensesج.م345.36m
Earningsج.م62.40m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin63.23%
Net Profit Margin9.68%
Debt/Equity Ratio307.4%

How did MCRO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/21 18:33
End of Day Share Price 2025/07/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Macro Group Pharmaceuticals (Macro Capital) S.A.E is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ahmed MoatazEFG-Hermes Research